About
Dr. Harish holds a Ph.D. in Gene Therapy and boasts a career spanning over a decade, characterised by significant contributions to the field. With a comprehensive skill set encompassing the design and execution of large-scale in-vitro and in-vivo experiments, he has demonstrated exceptional expertise in various advanced techniques, including immunohistochemical, molecular, and mass spectrometric applications. Dr. Harish's profound understanding of AAV vector production, statistical planning, and analysis of complex datasets has enabled the generation of valuable insights into drug screening, efficacy and the immunological aspects of gene therapy. His skills in grant writing, lab management and impressive publication record underscore his unwavering dedication and exceptional proficiency.
Dr. Harish's current research pursuits revolve around elucidating mechanisms underlying immunogenic responses to viral vectors and identifying proteomic biomarkers linked to toxicity in clinical settings.He is currently leading a multi-centre/national study into the immunological effects of Zolgensma, the gene therapy for Spinal Muscular Atrophy.